First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis
about
Developments with experimental and investigational drugs for axial spondyloarthritis.The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis.Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practiceDual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis.Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness.Shifting the Focus: The Primary Role of IL-23 in Psoriasis and other Inflammatory Disorders.Unmet Needs in the Field of Psoriasis: Pathogenesis and Treatment.The IL-17 Family of Cytokines in Psoriasis: IL-17A and BeyondNew Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis
P2860
Q38676714-9EB52908-94B7-40B4-BA86-714BEF06D70AQ38707588-1EAD24C2-02A9-4087-91D8-84826ABCD46FQ39153776-BE22F459-E121-403E-9983-B5E53FAEF9C9Q47253021-972831DC-5A8B-4DAE-8B43-F3E7CF470456Q48326905-10C791CE-DA48-44E1-AA4B-A78B51D9431FQ49276761-C09D54DC-ABF1-45AE-B1F2-6BF22BDCD866Q50041283-7BEF87DE-7A11-4576-9116-EE32AB110BC9Q53123754-6EEC27AC-D8C0-4BED-A2C3-2DCDE467A414Q58803307-83C13804-ED25-4D1F-8F91-ACEB68CC2569Q58803309-1DD3EEFE-2D0F-4C91-B733-6B8537749933
P2860
First-in-human randomized study of bimekizumab, a humanized monoclonal antibody and selective dual inhibitor of IL-17A and IL-17F, in mild psoriasis
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@ast
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@en
type
label
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@ast
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@en
prefLabel
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@ast
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@en
P2093
P2860
P356
P1476
First-in-human randomized stud ...... and IL-17F, in mild psoriasis
@en
P2093
Birgit Haier
Eric Helmer
Foteini Strimenopoulou
Graham Price
John Lambert
Olivier A Harari
Pavan Vajjah
Sophie Glatt
Stevan Shaw
P2860
P304
P356
10.1111/BCP.13185
P407
P577
2016-11-13T00:00:00Z